Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Meningococcal B Vaccine to Prevent <i>Neisseria gonorrhoeae</i> Infection.

The New England journal of medicine·2026
Same author

HIV cascade, key indicators, and other epidemiological metrics in Australia (2004-2023): a retrospective analysis.

The Lancet regional health. Western Pacific·2026
Same author

Barriers and Facilitators to Oral HIV Pre-exposure Prophylaxis Use in Australia: A Scoping Review Comparing Findings to Canada, New Zealand, and the United Kingdom.

AIDS and behavior·2026
Same author

Mpox disease epidemiology, vaccine uptake and vaccination coverage in Australia 2022-2024: a descriptive study.

EClinicalMedicine·2026
Same author

Barriers and Facilitators Related to Providing Long-Acting Injectable HIV Preexposure Prophylaxis in Australian Settings: A Qualitative Study of Clinical and Policy Stakeholders.

The Journal of the Association of Nurses in AIDS Care : JANAC·2026
Same author

Efficacy of the meningococcal vaccine against Neisseria gonorrhoeae: a randomised clinical trial (MenGO).

NPJ vaccines·2026

Related Experiment Video

Updated: May 22, 2026

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
18:46

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

Does ART prevent HIV transmission among MSM?

Kathryn E Muessig1, M Kumi Smith, Kimberly A Powers

  • 1Department of Medicine, University of North Carolina, Chapel Hill, USA.

AIDS (London, England)
|May 10, 2012
PubMed
Summary

Antiretroviral therapy (ART) likely helps prevent HIV transmission among men who have sex with men (MSM), but more research is needed to confirm its effectiveness and understand its impact globally.

More Related Videos

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
11:14

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

Published on: October 12, 2018

Related Experiment Videos

Last Updated: May 22, 2026

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
18:46

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
11:14

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

Published on: October 12, 2018

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • HIV remains a significant concern for men who have sex with men (MSM).
  • Antiretroviral therapy (ART) is increasingly used for HIV treatment and prevention.
  • The concept of 'treatment as prevention' (TasP) posits that ART can reduce HIV transmission.

Purpose of the Study:

  • To review evidence on the effectiveness of ART as a prevention strategy for HIV transmission among MSM.
  • To assess the biological and epidemiological support for TasP in this population.

Main Methods:

  • Systematic review of studies evaluating the biological plausibility of ART reducing HIV infectiousness.
  • Analysis of epidemiological data on HIV incidence among MSM before and after ART implementation.

Main Results:

  • ART likely offers some preventive benefits for HIV transmission among MSM.
  • The extent to which ART reduces infectiousness via anal intercourse requires further investigation, particularly regarding drug pharmacokinetics in the gastrointestinal tract.
  • Population-level benefits of ART may be limited by ongoing risk behaviors, condomless anal intercourse, and other sexually transmitted infections (STIs).
  • More research is needed on ART's impact in diverse global settings.

Conclusions:

  • While the benefits of TasP for MSM are highly plausible, they are not definitively proven.
  • Combination prevention strategies, including earlier diagnosis, expanded STI treatment, and behavioral interventions, are crucial alongside earlier ART initiation.